Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles-Reference-Cited by-同舟云学术

Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles

Published:2011-02-16 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

van Wely Madelon¹,Kwan Irene²,Burt Anna L³,Thomas Jane⁴,Vail Andy⁵,Van der Veen Fulco⁶,Al-Inany Hesham G⁷

Affiliation:

1. Academic Medical Centre, University of Amsterdam; Centre for Reproductive Medicine, Department of Obstetrics and Gynaecology; Center Meibergdreef 9 Amsterdam Netherlands 1105 AZ

2. Institute of Education, University of London; Evidence for Policy and Practice Information and Coordinating Centre (EPPI-Centre), Social Science Research Unit (SSRU); 10 Woburn Square London UK WC1H 0NR

3. The Royal College of Obstetricians & Gynaecologists; National Collaborating Centre for Women`s and Children`s Health; 27 Sussex Place, Regent´s Park London UK NW1 4RG

4. Auckland University; Cochrane MSDG FMHS; Grafton Campus Auckland New Zealand

5. University of Manchester; Health Methodology Research Group; R & D Support Unit, Salford Royal Hospital Stott Lane Salford UK M6 8HD

6. Academic Medical Center, University of Amsterdam; Center for Reproductive Medicine, Department of Obstetrics & Gynaecology; University of Amsterdam Meibergdreef 9 Amsterdam Netherlands 1105 AZ

7. Faculty of Medicine, Cairo University; Obstetrics & Gynaecology; 8 Moustapha Hassanin St Manial Cairo Egypt

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD005354.pub2/fullpdf

Reference79 articles.

1. Efficacy of recombinant versus human derived follicle stimulating hormone on the oocyte and embryo quality in IVF-ICSI cycles: randomized, controlled, multi-centre trial;Abate;Gynecological Endocrinology,2009

2. Alvino H Norman R.J Matthews C.D Recombinant human follicle stimulating hormone (Gonal-F,Serono) compared to urinary follicle stimulating hormone (Metrodin) in IVF cycles: a randomised control study Fertility Society of Australia/ Australasian Gynaecological endoscopy Society Conference, Melbourne, Australia. 19-25 November 1995

3. Clinical outcome following stimulation with highly purified HMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial;Andersen;Human Reproduction,2006

4. Influence of ovarian stimulation with HP-HMG or recombinant FSH on embryo quality parameters in patients undergoing IVF.;Ziebe;Human Reproduction,2007

5. Antoine J.M De Mouzon J Nicollet B Salle B Urbancsek J Grudzinskas J.G Effectiveness and tolerability of hFSH compared to rFSH in ICSI:the European study IBSA Satelite Symposium abstract, ESHRE, Lyon 2007

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Critical Analysis of the FDA’s Omics-Driven Pharmacodynamic Biomarkers to Establish Biosimilarity;Pharmaceuticals;2023-11-02

2. Assisted Reproductive Technology and Disease Management in Infertile Women with Multiple Sclerosis;CNS Drugs;2023-09-07

3. A reappraisal of ovarian stimulation strategies used in assisted reproductive technology;Human Fertility;2023-08-08

4. Interventions to prevent or reduce the incidence and severity of ovarian hyperstimulation syndrome: a systematic umbrella review of the best clinical evidence;Reproductive Biology and Endocrinology;2023-07-21

5. The therapeutic effects of rFSH versus uFSH/uHMG on ovarian stimulation in women undergoing assisted reproductive technology: a meta-analysis of randomized controlled trials;Archives of Gynecology and Obstetrics;2023-07-20